These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
645 related articles for article (PubMed ID: 16580440)
1. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440 [TBL] [Abstract][Full Text] [Related]
2. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407 [TBL] [Abstract][Full Text] [Related]
4. [Multimodal treatment of non small cell lung cancer]. Stoelben E; Digel W; Henke M; Passlick B Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776 [TBL] [Abstract][Full Text] [Related]
5. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy. Lee JD; Ginsberg RJ Ann Thorac Surg; 1996 Aug; 62(2):338-41. PubMed ID: 8694587 [TBL] [Abstract][Full Text] [Related]
6. Survival of patients with true pathologic stage I non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920 [TBL] [Abstract][Full Text] [Related]
7. Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy. Aabakken L; Silvestri GA; Hawes R; Reed CE; Marsi V; Hoffman B Endoscopy; 1999 Nov; 31(9):707-11. PubMed ID: 10604611 [TBL] [Abstract][Full Text] [Related]
8. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. Cerfolio RJ; Bryant AS; Ojha B J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150 [TBL] [Abstract][Full Text] [Related]
9. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA; Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324 [TBL] [Abstract][Full Text] [Related]
10. Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis. Ferguson MK J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1935-42. PubMed ID: 14688709 [TBL] [Abstract][Full Text] [Related]
11. [Clinical value of cervical mediastinoscopy in non-small cell lung cancer of stage I]. Zhang SY; Wang X; Zhu ZH; Zeng CG; Rong TH; Zheng L; Fu JH; Xie ZM; Zhang X; Yu H Ai Zheng; 2005 Mar; 24(3):349-52. PubMed ID: 15757540 [TBL] [Abstract][Full Text] [Related]
12. The validity of preoperative lymph node staging guidelines of European Society of Thoracic Surgeons in non-small-cell lung cancer patients. Gunluoglu MZ; Melek H; Medetoglu B; Demir A; Kara HV; Dincer SI Eur J Cardiothorac Surg; 2011 Aug; 40(2):287-90. PubMed ID: 21185733 [TBL] [Abstract][Full Text] [Related]
13. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer. von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730 [TBL] [Abstract][Full Text] [Related]
14. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients. Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763 [TBL] [Abstract][Full Text] [Related]
15. The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis. Søgaard R; Fischer BM; Mortensen J; Rasmussen TR; Lassen U Value Health; 2013; 16(1):57-65. PubMed ID: 23337216 [TBL] [Abstract][Full Text] [Related]
16. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. De Leyn P; Lardinois D; Van Schil PE; Rami-Porta R; Passlick B; Zielinski M; Waller DA; Lerut T; Weder W Eur J Cardiothorac Surg; 2007 Jul; 32(1):1-8. PubMed ID: 17448671 [TBL] [Abstract][Full Text] [Related]
17. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480 [TBL] [Abstract][Full Text] [Related]
18. Is routine mediastinoscopy indicated for patients with T1 non-small cell lung cancer? Dincer SI; Demir A; Akin H; Gunluoglu MZ; Metin M; Melek H; Gurses A Indian J Chest Dis Allied Sci; 2006; 48(4):249-52. PubMed ID: 16970289 [TBL] [Abstract][Full Text] [Related]
19. Mediastinal staging of lung cancer. Is mediastinoscopy still essential? Kristensen S; Aaby C; Nielsen SM Dan Med Bull; 1995 Apr; 42(2):192-4. PubMed ID: 7664577 [TBL] [Abstract][Full Text] [Related]
20. Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer. Cerfolio RJ; Bryant AS; Eloubeidi MA Ann Thorac Surg; 2007 Sep; 84(3):940-5. PubMed ID: 17720403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]